Back to Results
First PageMeta Content
Medical genetics / Ataxia telangiectasia / Genodermatoses / Proteins / Ataxia / Spinocerebellar ataxia / Neurodegenerative disorders / Health / Genetic genealogy


EryDel announces Positive Results with EryDex in patients with Ataxia Telangiectasia Significant benefit seen on Primary and Secondary end-points Urbino, Italy – February 29 - EryDel SpA ( www.erydel.com ), a Biotech C
Add to Reading List

Document Date: 2013-02-19 10:23:48

Open Document

File Size: 438,12 KB

Share Result on Facebook

City

Urbino / /

Company

EryDel SpA / /

Country

Italy / /

/

Facility

Hospital S / /

IndustryTerm

pharmaceutical / device technology / /

MedicalCondition

rare progressive neurological autosomal recessive disorder / /

MedicalTreatment

innovative therapies / drug targeting / /

Person

Luciana Chessa / S. Andrea / Giovanni Mambrini / /

Position

Investigator / Major / representative / General Manager / trained neurologist / /

Product

dexamethasone sodium phosphate / /

Technology

alpha / ATM / /

URL

www.erydel.com / /

SocialTag